Global GLP-1 Agonist Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 101

Published Date: 28 Mar 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.

According to our (Global Info Research) latest study, the global GLP-1 Agonist Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global GLP-1 Agonist Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global GLP-1 Agonist Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Agonist Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Agonist Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Agonist Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Agonist Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Agonist Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, AstraZeneca, GSK, Sanofi, Amylin, Huadong Medicine, Shanghai Benemae Pharmaceutical Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
GLP-1 Agonist Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Short-acting Preparations
    Long-acting Preparations

Market segment by Application
    Diabetes
    Obesity

Major players covered
    Novo Nordisk
    Eli Lilly
    AstraZeneca
    GSK
    Sanofi
    Amylin
    Huadong Medicine
    Shanghai Benemae Pharmaceutical Corporation

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1 Agonist Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Agonist Injection, with price, sales quantity, revenue, and global market share of GLP-1 Agonist Injection from 2019 to 2024.
Chapter 3, the GLP-1 Agonist Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Agonist Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and GLP-1 Agonist Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Agonist Injection.
Chapter 14 and 15, to describe GLP-1 Agonist Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global GLP-1 Agonist Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Short-acting Preparations
        1.3.3 Long-acting Preparations
    1.4 Market Analysis by Application
        1.4.1 Overview: Global GLP-1 Agonist Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Diabetes
        1.4.3 Obesity
    1.5 Global GLP-1 Agonist Injection Market Size & Forecast
        1.5.1 Global GLP-1 Agonist Injection Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global GLP-1 Agonist Injection Sales Quantity (2019-2030)
        1.5.3 Global GLP-1 Agonist Injection Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk GLP-1 Agonist Injection Product and Services
        2.1.4 Novo Nordisk GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Eli Lilly
        2.2.1 Eli Lilly Details
        2.2.2 Eli Lilly Major Business
        2.2.3 Eli Lilly GLP-1 Agonist Injection Product and Services
        2.2.4 Eli Lilly GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Eli Lilly Recent Developments/Updates
    2.3 AstraZeneca
        2.3.1 AstraZeneca Details
        2.3.2 AstraZeneca Major Business
        2.3.3 AstraZeneca GLP-1 Agonist Injection Product and Services
        2.3.4 AstraZeneca GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 AstraZeneca Recent Developments/Updates
    2.4 GSK
        2.4.1 GSK Details
        2.4.2 GSK Major Business
        2.4.3 GSK GLP-1 Agonist Injection Product and Services
        2.4.4 GSK GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 GSK Recent Developments/Updates
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi GLP-1 Agonist Injection Product and Services
        2.5.4 Sanofi GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sanofi Recent Developments/Updates
    2.6 Amylin
        2.6.1 Amylin Details
        2.6.2 Amylin Major Business
        2.6.3 Amylin GLP-1 Agonist Injection Product and Services
        2.6.4 Amylin GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Amylin Recent Developments/Updates
    2.7 Huadong Medicine
        2.7.1 Huadong Medicine Details
        2.7.2 Huadong Medicine Major Business
        2.7.3 Huadong Medicine GLP-1 Agonist Injection Product and Services
        2.7.4 Huadong Medicine GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Huadong Medicine Recent Developments/Updates
    2.8 Shanghai Benemae Pharmaceutical Corporation
        2.8.1 Shanghai Benemae Pharmaceutical Corporation Details
        2.8.2 Shanghai Benemae Pharmaceutical Corporation Major Business
        2.8.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product and Services
        2.8.4 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates

3 Competitive Environment: GLP-1 Agonist Injection by Manufacturer
    3.1 Global GLP-1 Agonist Injection Sales Quantity by Manufacturer (2019-2024)
    3.2 Global GLP-1 Agonist Injection Revenue by Manufacturer (2019-2024)
    3.3 Global GLP-1 Agonist Injection Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of GLP-1 Agonist Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 GLP-1 Agonist Injection Manufacturer Market Share in 2023
        3.4.3 Top 6 GLP-1 Agonist Injection Manufacturer Market Share in 2023
    3.5 GLP-1 Agonist Injection Market: Overall Company Footprint Analysis
        3.5.1 GLP-1 Agonist Injection Market: Region Footprint
        3.5.2 GLP-1 Agonist Injection Market: Company Product Type Footprint
        3.5.3 GLP-1 Agonist Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global GLP-1 Agonist Injection Market Size by Region
        4.1.1 Global GLP-1 Agonist Injection Sales Quantity by Region (2019-2030)
        4.1.2 Global GLP-1 Agonist Injection Consumption Value by Region (2019-2030)
        4.1.3 Global GLP-1 Agonist Injection Average Price by Region (2019-2030)
    4.2 North America GLP-1 Agonist Injection Consumption Value (2019-2030)
    4.3 Europe GLP-1 Agonist Injection Consumption Value (2019-2030)
    4.4 Asia-Pacific GLP-1 Agonist Injection Consumption Value (2019-2030)
    4.5 South America GLP-1 Agonist Injection Consumption Value (2019-2030)
    4.6 Middle East & Africa GLP-1 Agonist Injection Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    5.2 Global GLP-1 Agonist Injection Consumption Value by Type (2019-2030)
    5.3 Global GLP-1 Agonist Injection Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    6.2 Global GLP-1 Agonist Injection Consumption Value by Application (2019-2030)
    6.3 Global GLP-1 Agonist Injection Average Price by Application (2019-2030)

7 North America
    7.1 North America GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    7.2 North America GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    7.3 North America GLP-1 Agonist Injection Market Size by Country
        7.3.1 North America GLP-1 Agonist Injection Sales Quantity by Country (2019-2030)
        7.3.2 North America GLP-1 Agonist Injection Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    8.2 Europe GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    8.3 Europe GLP-1 Agonist Injection Market Size by Country
        8.3.1 Europe GLP-1 Agonist Injection Sales Quantity by Country (2019-2030)
        8.3.2 Europe GLP-1 Agonist Injection Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific GLP-1 Agonist Injection Market Size by Region
        9.3.1 Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific GLP-1 Agonist Injection Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    10.2 South America GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    10.3 South America GLP-1 Agonist Injection Market Size by Country
        10.3.1 South America GLP-1 Agonist Injection Sales Quantity by Country (2019-2030)
        10.3.2 South America GLP-1 Agonist Injection Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa GLP-1 Agonist Injection Market Size by Country
        11.3.1 Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa GLP-1 Agonist Injection Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 GLP-1 Agonist Injection Market Drivers
    12.2 GLP-1 Agonist Injection Market Restraints
    12.3 GLP-1 Agonist Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of GLP-1 Agonist Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of GLP-1 Agonist Injection
    13.3 GLP-1 Agonist Injection Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 GLP-1 Agonist Injection Typical Distributors
    14.3 GLP-1 Agonist Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global GLP-1 Agonist Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global GLP-1 Agonist Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
 Table 4. Novo Nordisk Major Business
 Table 5. Novo Nordisk GLP-1 Agonist Injection Product and Services
 Table 6. Novo Nordisk GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Novo Nordisk Recent Developments/Updates
 Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 9. Eli Lilly Major Business
 Table 10. Eli Lilly GLP-1 Agonist Injection Product and Services
 Table 11. Eli Lilly GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Eli Lilly Recent Developments/Updates
 Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 14. AstraZeneca Major Business
 Table 15. AstraZeneca GLP-1 Agonist Injection Product and Services
 Table 16. AstraZeneca GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. AstraZeneca Recent Developments/Updates
 Table 18. GSK Basic Information, Manufacturing Base and Competitors
 Table 19. GSK Major Business
 Table 20. GSK GLP-1 Agonist Injection Product and Services
 Table 21. GSK GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. GSK Recent Developments/Updates
 Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 24. Sanofi Major Business
 Table 25. Sanofi GLP-1 Agonist Injection Product and Services
 Table 26. Sanofi GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Sanofi Recent Developments/Updates
 Table 28. Amylin Basic Information, Manufacturing Base and Competitors
 Table 29. Amylin Major Business
 Table 30. Amylin GLP-1 Agonist Injection Product and Services
 Table 31. Amylin GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Amylin Recent Developments/Updates
 Table 33. Huadong Medicine Basic Information, Manufacturing Base and Competitors
 Table 34. Huadong Medicine Major Business
 Table 35. Huadong Medicine GLP-1 Agonist Injection Product and Services
 Table 36. Huadong Medicine GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Huadong Medicine Recent Developments/Updates
 Table 38. Shanghai Benemae Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
 Table 39. Shanghai Benemae Pharmaceutical Corporation Major Business
 Table 40. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product and Services
 Table 41. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
 Table 43. Global GLP-1 Agonist Injection Sales Quantity by Manufacturer (2019-2024) & (K Dose)
 Table 44. Global GLP-1 Agonist Injection Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 45. Global GLP-1 Agonist Injection Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 46. Market Position of Manufacturers in GLP-1 Agonist Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 47. Head Office and GLP-1 Agonist Injection Production Site of Key Manufacturer
 Table 48. GLP-1 Agonist Injection Market: Company Product Type Footprint
 Table 49. GLP-1 Agonist Injection Market: Company Product Application Footprint
 Table 50. GLP-1 Agonist Injection New Market Entrants and Barriers to Market Entry
 Table 51. GLP-1 Agonist Injection Mergers, Acquisition, Agreements, and Collaborations
 Table 52. Global GLP-1 Agonist Injection Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 53. Global GLP-1 Agonist Injection Sales Quantity by Region (2019-2024) & (K Dose)
 Table 54. Global GLP-1 Agonist Injection Sales Quantity by Region (2025-2030) & (K Dose)
 Table 55. Global GLP-1 Agonist Injection Consumption Value by Region (2019-2024) & (USD Million)
 Table 56. Global GLP-1 Agonist Injection Consumption Value by Region (2025-2030) & (USD Million)
 Table 57. Global GLP-1 Agonist Injection Average Price by Region (2019-2024) & (US$/Dose)
 Table 58. Global GLP-1 Agonist Injection Average Price by Region (2025-2030) & (US$/Dose)
 Table 59. Global GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 60. Global GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 61. Global GLP-1 Agonist Injection Consumption Value by Type (2019-2024) & (USD Million)
 Table 62. Global GLP-1 Agonist Injection Consumption Value by Type (2025-2030) & (USD Million)
 Table 63. Global GLP-1 Agonist Injection Average Price by Type (2019-2024) & (US$/Dose)
 Table 64. Global GLP-1 Agonist Injection Average Price by Type (2025-2030) & (US$/Dose)
 Table 65. Global GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 66. Global GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 67. Global GLP-1 Agonist Injection Consumption Value by Application (2019-2024) & (USD Million)
 Table 68. Global GLP-1 Agonist Injection Consumption Value by Application (2025-2030) & (USD Million)
 Table 69. Global GLP-1 Agonist Injection Average Price by Application (2019-2024) & (US$/Dose)
 Table 70. Global GLP-1 Agonist Injection Average Price by Application (2025-2030) & (US$/Dose)
 Table 71. North America GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 72. North America GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 73. North America GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 74. North America GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 75. North America GLP-1 Agonist Injection Sales Quantity by Country (2019-2024) & (K Dose)
 Table 76. North America GLP-1 Agonist Injection Sales Quantity by Country (2025-2030) & (K Dose)
 Table 77. North America GLP-1 Agonist Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 78. North America GLP-1 Agonist Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 79. Europe GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 80. Europe GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 81. Europe GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 82. Europe GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 83. Europe GLP-1 Agonist Injection Sales Quantity by Country (2019-2024) & (K Dose)
 Table 84. Europe GLP-1 Agonist Injection Sales Quantity by Country (2025-2030) & (K Dose)
 Table 85. Europe GLP-1 Agonist Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 86. Europe GLP-1 Agonist Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 87. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 88. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 89. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 90. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 91. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Region (2019-2024) & (K Dose)
 Table 92. Asia-Pacific GLP-1 Agonist Injection Sales Quantity by Region (2025-2030) & (K Dose)
 Table 93. Asia-Pacific GLP-1 Agonist Injection Consumption Value by Region (2019-2024) & (USD Million)
 Table 94. Asia-Pacific GLP-1 Agonist Injection Consumption Value by Region (2025-2030) & (USD Million)
 Table 95. South America GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 96. South America GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 97. South America GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 98. South America GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 99. South America GLP-1 Agonist Injection Sales Quantity by Country (2019-2024) & (K Dose)
 Table 100. South America GLP-1 Agonist Injection Sales Quantity by Country (2025-2030) & (K Dose)
 Table 101. South America GLP-1 Agonist Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 102. South America GLP-1 Agonist Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 103. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Type (2019-2024) & (K Dose)
 Table 104. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Type (2025-2030) & (K Dose)
 Table 105. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Application (2019-2024) & (K Dose)
 Table 106. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Application (2025-2030) & (K Dose)
 Table 107. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Country (2019-2024) & (K Dose)
 Table 108. Middle East & Africa GLP-1 Agonist Injection Sales Quantity by Country (2025-2030) & (K Dose)
 Table 109. Middle East & Africa GLP-1 Agonist Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 110. Middle East & Africa GLP-1 Agonist Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 111. GLP-1 Agonist Injection Raw Material
 Table 112. Key Manufacturers of GLP-1 Agonist Injection Raw Materials
 Table 113. GLP-1 Agonist Injection Typical Distributors
 Table 114. GLP-1 Agonist Injection Typical Customers


List of Figures
 Figure 1. GLP-1 Agonist Injection Picture
 Figure 2. Global GLP-1 Agonist Injection Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global GLP-1 Agonist Injection Revenue Market Share by Type in 2023
 Figure 4. Short-acting Preparations Examples
 Figure 5. Long-acting Preparations Examples
 Figure 6. Global GLP-1 Agonist Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global GLP-1 Agonist Injection Revenue Market Share by Application in 2023
 Figure 8. Diabetes Examples
 Figure 9. Obesity Examples
 Figure 10. Global GLP-1 Agonist Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global GLP-1 Agonist Injection Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global GLP-1 Agonist Injection Sales Quantity (2019-2030) & (K Dose)
 Figure 13. Global GLP-1 Agonist Injection Price (2019-2030) & (US$/Dose)
 Figure 14. Global GLP-1 Agonist Injection Sales Quantity Market Share by Manufacturer in 2023
 Figure 15. Global GLP-1 Agonist Injection Revenue Market Share by Manufacturer in 2023
 Figure 16. Producer Shipments of GLP-1 Agonist Injection by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 17. Top 3 GLP-1 Agonist Injection Manufacturer (Revenue) Market Share in 2023
 Figure 18. Top 6 GLP-1 Agonist Injection Manufacturer (Revenue) Market Share in 2023
 Figure 19. Global GLP-1 Agonist Injection Sales Quantity Market Share by Region (2019-2030)
 Figure 20. Global GLP-1 Agonist Injection Consumption Value Market Share by Region (2019-2030)
 Figure 21. North America GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 22. Europe GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 23. Asia-Pacific GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 24. South America GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 25. Middle East & Africa GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 26. Global GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 27. Global GLP-1 Agonist Injection Consumption Value Market Share by Type (2019-2030)
 Figure 28. Global GLP-1 Agonist Injection Average Price by Type (2019-2030) & (US$/Dose)
 Figure 29. Global GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 30. Global GLP-1 Agonist Injection Revenue Market Share by Application (2019-2030)
 Figure 31. Global GLP-1 Agonist Injection Average Price by Application (2019-2030) & (US$/Dose)
 Figure 32. North America GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 33. North America GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 34. North America GLP-1 Agonist Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 35. North America GLP-1 Agonist Injection Consumption Value Market Share by Country (2019-2030)
 Figure 36. United States GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 37. Canada GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 38. Mexico GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 39. Europe GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 40. Europe GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 41. Europe GLP-1 Agonist Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 42. Europe GLP-1 Agonist Injection Consumption Value Market Share by Country (2019-2030)
 Figure 43. Germany GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 44. France GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 45. United Kingdom GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 46. Russia GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 47. Italy GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 48. Asia-Pacific GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 49. Asia-Pacific GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 50. Asia-Pacific GLP-1 Agonist Injection Sales Quantity Market Share by Region (2019-2030)
 Figure 51. Asia-Pacific GLP-1 Agonist Injection Consumption Value Market Share by Region (2019-2030)
 Figure 52. China GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 53. Japan GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 54. South Korea GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 55. India GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 56. Southeast Asia GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 57. Australia GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 58. South America GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 59. South America GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 60. South America GLP-1 Agonist Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 61. South America GLP-1 Agonist Injection Consumption Value Market Share by Country (2019-2030)
 Figure 62. Brazil GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 63. Argentina GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 64. Middle East & Africa GLP-1 Agonist Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 65. Middle East & Africa GLP-1 Agonist Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 66. Middle East & Africa GLP-1 Agonist Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 67. Middle East & Africa GLP-1 Agonist Injection Consumption Value Market Share by Country (2019-2030)
 Figure 68. Turkey GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 69. Egypt GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 70. Saudi Arabia GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 71. South Africa GLP-1 Agonist Injection Consumption Value (2019-2030) & (USD Million)
 Figure 72. GLP-1 Agonist Injection Market Drivers
 Figure 73. GLP-1 Agonist Injection Market Restraints
 Figure 74. GLP-1 Agonist Injection Market Trends
 Figure 75. Porters Five Forces Analysis
 Figure 76. Manufacturing Cost Structure Analysis of GLP-1 Agonist Injection in 2023
 Figure 77. Manufacturing Process Analysis of GLP-1 Agonist Injection
 Figure 78. GLP-1 Agonist Injection Industrial Chain
 Figure 79. Sales Channel: Direct to End-User vs Distributors
 Figure 80. Direct Channel Pros & Cons
 Figure 81. Indirect Channel Pros & Cons
 Figure 82. Methodology
 Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novo Nordisk
Eli Lilly
AstraZeneca
GSK
Sanofi
Amylin
Huadong Medicine
Shanghai Benemae Pharmaceutical Corporation

Related Reports

Global GLP-1 Agonist Injection Supply, Demand and Key Producers, 2024-2030

Global GLP-1 Agonist Injection Supply, Demand and Key Producers, 2024-2030

date 28 Mar 2024

date Pharma & Healthcare

GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.

Product Tags

GLP-1 Agonist Injection

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>